Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis

Biologics used in the treatment of rheumatoid arthritis (RA) rarely cause eosinophilia. We herein report a patient with RA being treated with infliximab, adalimumab, and tocilizumab who developed eosinophilia with skin symptoms. Interestingly, the marked eosinophilia and skin symptoms did not reappe...

Descripción completa

Detalles Bibliográficos
Autores principales: Azuma, Naoto, Matsui, Kiyoshi, Hashimoto, Naoaki, Yoshikawa, Takahiro, Sano, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505919/
https://www.ncbi.nlm.nih.gov/pubmed/28626189
http://dx.doi.org/10.2169/internalmedicine.56.8168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505919/
https://www.ncbi.nlm.nih.gov/pubmed/28626189
http://dx.doi.org/10.2169/internalmedicine.56.8168

Ejemplares similares